173 related articles for article (PubMed ID: 10701504)
1. Tumour control probability: a formulation applicable to any temporal protocol of dose delivery.
Zaider M; Minerbo GN
Phys Med Biol; 2000 Feb; 45(2):279-93. PubMed ID: 10701504
[TBL] [Abstract][Full Text] [Related]
2. Application of the equivalent uniform stochastic dose (EUSD) to TCP calculations incorporating dose uncertainty and fractionation effects.
Zavgorodni S
Australas Phys Eng Sci Med; 2008 Mar; 31(1):1-9. PubMed ID: 18488958
[TBL] [Abstract][Full Text] [Related]
3. Viability of the EUD and TCP concepts as reliable dose indicators.
Ebert MA
Phys Med Biol; 2000 Feb; 45(2):441-57. PubMed ID: 10701514
[TBL] [Abstract][Full Text] [Related]
4. Are more complicated tumour control probability models better?
Gong J; Dos Santos MM; Finlay C; Hillen T
Math Med Biol; 2013 Mar; 30(1):1-19. PubMed ID: 22006625
[TBL] [Abstract][Full Text] [Related]
5. Optimization of tumour control probability for heterogeneous tumours in fractionated radiotherapy treatment protocols.
Levin-Plotnik D; Hamilton RJ
Phys Med Biol; 2004 Feb; 49(3):407-24. PubMed ID: 15012010
[TBL] [Abstract][Full Text] [Related]
6. A stochastic model for tumour control probability that accounts for repair from sublethal damage.
Ponce Bobadilla AV; Maini PK; Byrne H
Math Med Biol; 2018 Jun; 35(2):181-202. PubMed ID: 28339783
[TBL] [Abstract][Full Text] [Related]
7. Predicting the radiation control probability of heterogeneous tumour ensembles: data analysis and parameter estimation using a closed-form expression.
Fenwick JD
Phys Med Biol; 1998 Aug; 43(8):2159-78. PubMed ID: 9725596
[TBL] [Abstract][Full Text] [Related]
8. Radiobiological parameters in a tumour control probability model for prostate cancer LDR brachytherapy.
Her EJ; Reynolds HM; Mears C; Williams S; Moorehouse C; Millar JL; Ebert MA; Haworth A
Phys Med Biol; 2018 Jun; 63(13):135011. PubMed ID: 29799812
[TBL] [Abstract][Full Text] [Related]
9. Cell-cycle times and the tumour control probability.
Maler A; Lutscher F
Math Med Biol; 2010 Dec; 27(4):313-42. PubMed ID: 19966342
[TBL] [Abstract][Full Text] [Related]
10. Do We Preserve Tumor Control Probability (TCP) in FLASH Radiotherapy? A Model-Based Analysis.
Liew H; Mein S; Tessonnier T; Abdollahi A; Debus J; Dokic I; Mairani A
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982185
[TBL] [Abstract][Full Text] [Related]
11. Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models.
King CR; DiPetrillo TA; Wazer DE
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):165-72. PubMed ID: 10656389
[TBL] [Abstract][Full Text] [Related]
12. Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study.
Søvik A; Malinen E; Bruland ØS; Bentzen SM; Olsen DR
Phys Med Biol; 2007 Jan; 52(2):499-513. PubMed ID: 17202629
[TBL] [Abstract][Full Text] [Related]
13. Should single or distributed parameters be used to explain the steepness of tumour control probability curves?
Daşu A; Toma-Daşu I; Fowler JF
Phys Med Biol; 2003 Feb; 48(3):387-97. PubMed ID: 12608614
[TBL] [Abstract][Full Text] [Related]
14. Coupling I-125 permanent implant prostate brachytherapy Monte Carlo dose calculations with radiobiological models.
Miksys N; Haidari M; Vigneault E; Martin AG; Beaulieu L; Thomson RM
Med Phys; 2017 Aug; 44(8):4329-4340. PubMed ID: 28455849
[TBL] [Abstract][Full Text] [Related]
15. Some characteristics of tumour control probability for heterogeneous tumours.
Ebert MA; Hoban PW
Phys Med Biol; 1996 Oct; 41(10):2125-33. PubMed ID: 8912385
[TBL] [Abstract][Full Text] [Related]
16. Optimum parameters in a model for tumour control probability, including interpatient heterogeneity: evaluation of the log-normal distribution.
Keall PJ; Webb S
Phys Med Biol; 2007 Jan; 52(1):291-302. PubMed ID: 17183142
[TBL] [Abstract][Full Text] [Related]
17. An evaluation method of clinical impact with setup, range, and radiosensitivity uncertainties in fractionated carbon-ion therapy.
Sakama M; Kanematsu N
Phys Med Biol; 2018 Jun; 63(13):135003. PubMed ID: 29863484
[TBL] [Abstract][Full Text] [Related]
18. Comparison between the ideal reference dose level and the actual reference dose level from clinical 3D radiotherapy treatment plans.
Bufacchi A; Arcangeli G; delle Canne S; Malatesta T; Capparella R; Fragomeni R; Marmiroli L; Begnozzi L
Radiother Oncol; 2009 Jul; 92(1):68-75. PubMed ID: 19328571
[TBL] [Abstract][Full Text] [Related]
19. Impact of dose and sensitivity heterogeneity on TCP.
Wiklund K; Toma-Dasu I; Lind BK
Comput Math Methods Med; 2014; 2014():182935. PubMed ID: 24899915
[TBL] [Abstract][Full Text] [Related]
20. The influence of dose heterogeneity on tumour control probability in fractionated radiation therapy.
Wiklund K; Toma-Dasu I; Lind BK
Phys Med Biol; 2011 Dec; 56(23):7585-600. PubMed ID: 22086189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
